The Journal of Immunology · 2012 · 107 citations · 12 references
Life SciencesImmunologyInfectious DiseasesImmunizationVaccine ImmunologyVaccinologyAdjuvant DesignAdjuvant DevelopmentHumoral ImmunityTuberculosis VaccinationVaccine DeliveryVaccine FormulationAdjuvant DeliveryEmulsion-based FormulationsEmulsion-based Vaccine AdjuvantsEmulsionsImmunological AdjuvantsOil-in-water AdjuvantsOil-in-water Emulsion SystemsSynthetic Adjuvants
An effective protein-based vaccine for tuberculosis will require a safe and effective adjuvant. There are few adjuvants in approved human vaccines, including alum and the oil-in-water-based emulsions MF59 (Novartis Vaccines and Diagnostics), AS03 and AS04 (GlaxoSmithKline Biologics), AF03 (Sanofi), and liposomes (Crucell). When used with pure, defined proteins, both alum and emulsion adjuvants are effective at inducing primarily humoral responses. One of the newest adjuvants in approved products is AS04, which combines monophosphoryl lipid A, a TLR-4 agonist, with alum. In this study, we compared two adjuvants: a stable oil-in-water emulsion (SE) and a stable oil-in-water emulsion incorporating glucopyranosyl lipid adjuvant, a synthetic TLR-4 agonist (GLA-SE), each together with a recombinant protein, ID93. Both the emulsion SE and GLA-SE adjuvants induce potent cellular responses in combination with ID93 in mice. ID93/SE induced Th2-biased immune responses, whereas ID93/GLA-SE induced multifunctional CD4(+) Th1 cell responses (IFN-γ, TNF-α, and IL-2). The ID93/GLA-SE vaccine candidate induced significant protection in mice and guinea pigs, whereas no protection was observed with ID93/SE, as assessed by reductions in bacterial burden, survival, and pathology. These results highlight the importance of properly formulating subunit vaccines with effective adjuvants for use against tuberculosis.
12
Global tuberculosis control 2010
Digambar Behera · The Indian Journal of Medical Research · 2012 · 1.3K citations · Full text
Public Health, Infectious Disease Control, Infectious Diseases +10
Sylvie Bertholet, Gregory C. Ireton, Diane Ordway et al. · Science Translational Medicine · 2010 · 302 citations · Full text
A Synthetic Adjuvant to Enhance and Expand Immune Responses to Influenza Vaccines
Rhea N. Coler, Susan L. Baldwin, Narek Shaverdian et al. · PLoS ONE · 2010 · 145 citations · Full text